Case Control Study
Copyright ©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 105208
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.105208
Table 1 Oligonucleotides used in this study
Primer set name
Reverse transcriptase reaction primer (5’ to 3’)
Real-time quantitative PCR primer (5’ to 3’)
miRNA-155-5pGTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAACCCCForward: TCGCTTTAATGCTAATCGTGATA
Reverse: CCAGTGCAGGGTCCGAGGTA
miRNA-26a-5pGTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAGCCTAForward: TCGCTTTCAAGTAATCCAGGA
Reverse: CCAGTGCAGGGTCCGAGGTA
miRNA-29a-3pGTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTAACCGForward: TCGCTTAGCACCATCTGAAAT
Reverse: CCAGTGCAGGGTCCGAGGTA
U6GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAAAATATGGAACGCTTForward: AGAAGATTAGCATGGCCCCTG
Reverse: CCAGTGCAGGGTCCGAGGTA
Table 2 Demographic characteristics of the study subjects
Characteristics
Healthy control
UTI
UGTB
n706989
Gender (male), n (%)32 (45.71)35 (50.72)43 (48.31)
Age (year), mean ± SD40 ± 1542 ± 1442 ± 15
Age (groups), n
18-35 years352736
35-50 years151819
51-65 years202434
Table 3 Culture results of 69 Urinary tract infection samples
Organism
Number
Escherichia coli40
Other lactose fermenters5
Non-lactose fermenters8
Gram positive organisms17
Table 4 Mycobacterium tuberculosis culture results of 89 urogenital tuberculosis samples
Mycobacterium tuberculosis
Culture results
Culture positive18
Culture sterile55
Contamination01
Only smear15
Table 5 Receivers operating characteristic curve comparison with cut-off values, sensitivity, specificity and likelihood ratio
Classification
Cut-off
Sensitivity (%)
95%CI
Specificity (%)
95%CI
Likelihood ratio
UGTB vs UTI
miRNA-155-5p> 2.68078.9556.67%-91.49%85.0063.96%-94.76%5.263
miRNA-29a-3p< 2.94565.0043.29%-81.88%85.0063.96%-94.76%4.333
UGTB vs HC
miRNA-155-5p> 2.32065.0043.29%-81.88%70.0048.10%-85.45%2.167
miRNA-26a-5p> 1.56570.0048.10%-85.45%75.0053.13%-88.81%2.800